🇺🇸 FDA
Pipeline program

Icotrokinra

77242113CRD3001

Phase 3 small_molecule active

Quick answer

Icotrokinra for Crohn Disease is a Phase 3 program (small_molecule) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen Cilag International NV
Indication
Crohn Disease
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials